Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bertero

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Melanoma Research|April 1, 1993
Therapy for metastatic melanoma: effective combination of dacarbazine, carmustine, cisplatin and tamoxifenM T Fierro, M Bertero, M Novelli, et al.
Melanoma Research|June 1, 1996
Low-dose integrated chemoimmuno-hormonotherapy with cisplatin, subcutaneous interleukin-2, alpha-interferon and tamoxifen for advanced metastatic melanoma--a pilot studyM G Bernengo, G C Doveil, M Bertero, et al.
Gut|July 20, 2007
Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potentialL Valfrè di Bonzo, I Ferrero, C Cravanzola, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Melanoma Research|April 1, 1993
Therapy for metastatic melanoma: effective combination of dacarbazine, carmustine, cisplatin and tamoxifenM T Fierro, M Bertero, M Novelli, et al.
Melanoma Research|June 1, 1996
Low-dose integrated chemoimmuno-hormonotherapy with cisplatin, subcutaneous interleukin-2, alpha-interferon and tamoxifen for advanced metastatic melanoma--a pilot studyM G Bernengo, G C Doveil, M Bertero, et al.
Gut|July 20, 2007
Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potentialL Valfrè di Bonzo, I Ferrero, C Cravanzola, et al.
Pageof 3